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Based onknowledge from traditional Arab herbal medicine, this in vitro study aimsto examine the anti-inﬂammatorymechanism
of Hypericum triquetrifolium by measuring the expression and release of pro-inﬂammatory cytokines, tumor necrosis factor-α
(TNF-α) andinterleukine-6 (IL-6),andinducible nitricoxidesynthase(iNOS)inhumanmonocyticcells, THP-1.The eﬀects were
assessed by measuring the levels of secretory proteins and mRNA of TNF-α and IL-6, the levels of nitric oxide (NO) secretion
and the expression of iNOS in THP-1 cells. Cells were treated with 5μg lipopolysaccharide/ml (LPS) in the presence and absence
of increasing concentrations of extracts from the aerial parts of H. triquetrifolium. During the entire experimental period, we
used extract concentrations(up to 250μgmL −1) that had no cytotoxic eﬀects, as measured with MTT and LDH assays.Hypericum
triquetrifolium extracts remarkablysuppressedtheLPS-inducedNOrelease,signiﬁcantlyattenuatedtheLPS-inducedtranscription
of iNOS and inhibited in a dose-dependent manner the expression and release of TNF-α. No signiﬁcant eﬀects were observed on
the release of IL-6. Taken together, these results suggest that H. triquetrifolium probably exerts anti-inﬂammatory eﬀects through
the suppression of TNF-α and iNOS expressions.
1.Introduction
In response to tissue injury, a multifactorial network of
chemical signals initiate and maintain a host response
designed to “heal” the aﬄicted tissue. This involves acti-
vation and directed migration of leukocytes (neutrophils,
monocytes and eosinophils) from the venous system to sites
of damage. Inﬂammation is the ﬁrst response of the immune
system to infection or irritation. It is caused by cytokines
such as tumor necrosis factor-α (TNF-α,i n t e r l e u k i n - 1( I L -
1) and interleukin-6 (IL-6) [1, 2] and by eicosanoid such as
PGE2 [3].
1.1. The Role of Proinﬂammatory Cytokines. Cytokines are
regulators of host responses to infection, immune responses,
inﬂammation and trauma. There are two types of cytokines:
pro-inﬂammatory and anti-inﬂammatory. Thus, inhibitors
of the pro-inﬂammatory cytokines have been considered as
a candidate of anti-inﬂammatory drugs. Lipopolysaccharide
(LPS)-activated macrophages are usually used for evaluating
the anti-inﬂammatory eﬀects of various materials. LPS is
the principle component of the outer membrane of Gram-
negative bacteria, is an endotoxin that induces septic shock
syndrome and stimulates the production of inﬂammatory
mediators such as nitric oxide (NO), TNF-α,i n t e r l e u k i n s ,
prostanoids and leukotrienes [4–6]. Therefore, LPS plays a
key role in not only eliciting an inﬂammatory response but
also in causing a septic shock during gram-negative bacterial
infection. Inﬂammatory responses are advantageous for
eradicating bacteria, as long as they are under control. When
out of control, however, deregulated inﬂammation leads to
the massive production of pro-inﬂammatory cytokines such
as TNF-α,I L - 1a n dI L - 6b ym a c r o p h a g e s[ 1, 7], which
can cause tissue injury and multiple organ failure [8]. For
example, the resident macrophages of the liver, the Kupﬀer
cells, are among the ﬁrst to respond to foreign antigens.2 Evidence-Based Complementary and Alternative Medicine
Activated hepatic Kupﬀer cells play an essential role in LPS-
induced liver injury [9]. Following contact with the CD14
protein, the complex triggers a signal cascade involving
nuclear factor kappa B (NF-κB). This factor enhances the
expression of inﬂammation-related genes. The acute-phase
response is regulated by cytokines released by activated
Kupﬀercells, notablyIL-1, IL-6, and TNF-α[10–12].Among
these cytokines, IL-6, also known as hepatocyte-stimulating
factor, is a major inducer of the acute-phase response. In
the liver, TNF-α production is not restricted to Kupﬀer cells.
Saad et al. [13]h a v ed e m o n s t r a t e dt h a tL P Sa ﬀects the acute-
phase response via hepatocyte-derived IL-6 and TNF-α in
an autocrine loop and the NO production of parenchymal
liver cells. TNF-α is also involved in inducing cell damage
by promoting oxidative stress in mitochondria [14]. TNF-α
stimulates the production of reactive oxygen species (ROS)
and reactive nitrogen species. ROS have been implicated in
the pathogenesis of many forms of liver disease. When liver
cells are exposed to excesses of ROS, oxidative stress occurs
and aﬀects many cellular functions. The inﬂammatory
process is controlled by immunosuppression cytokines such
as interleukin-10 (IL-10) and interleukin-4. Macrophage-
derived IL-10 aﬀects the growth and diﬀerentiation of
various cell types of the immune system in vitro. It inhibits
the production of inﬂammatory cytokines such as IL-1, IL-6
and TNF-α by LPS-activated macrophages.
1.2. Medicinal Plants. Despite the great progress in modern
medicine, traditional medicine has always been practiced in
the Arab-Islamic world. Cultural beliefs and practices often
led to self-medication, use of home remedies and consul-
tation with traditional healers in rural areas. Traditional
therapies have been utilized by people in the Mediterranean
region, who have faith in spiritual healers, homeopaths or
even many herbalists. These therapies are the ﬁrst choice for
peoplewith problemssuchasinfertility, impotence,diabetes,
obesity, epilepsy, psychosomatic troubles and many other
diseases.Arabicherbalmedicinehasplayedaremarkablerole
in curing inﬂammatory diseases in general and in clearly
distinguishing between several subtypes of inﬂammatory
diseases and has identiﬁed the curative properties of tens of
plants for treating various types of inﬂammations [15–19].
1.3. Hypericum triquetrifolium. Herbal medicines contain-
ing Hypericum triquetrifolium have been used in traditional
Arab herbal medicine totreat various inﬂammatory diseases.
T h ec l a s s i cA r a b i cn a m ef o rt h i sp l a n ts p e c i e si sDathi
or Nabtat Yohanna [15–19]. Our previous studies show
that H. triquetrifolium is not used any more within the
practitioner communities in Galilee and in West Bank. This
fact reﬂects an extinction process of important elements of
the Arab herbal medicine heritage [15–19]. Utilizing the
knowledge derived from traditional Arab herbal medicine
and a recent in vivo report in which H. triquetrifolium
extract exhibited anti-inﬂammatory activity in rats [20],
this study explored the anti-inﬂammatory mechanism of H.
triquetrifolium. Therefore, the expression and release of pro-
inﬂammatory cytokines TNF-α and IL-6 and the inducible
nitric oxide synthase (iNOS) in human monocytic cells,
THP-1, weremeasured. OurresultsindicatethatH.triquetri-
folium could modulate the regulatory mechanism of NO and
pro-inﬂammatory cytokines (TNF-α and IL-6) in the LPS-
activated THP-1 cells. Hypericum triquetrifolium inhibited
the production of NO and TNF-α and the expression of
iNOS and TNF-α but not of IL-6.
2.Methods
2.1. Preparation of Plant Extracts. One-hundred grams of
air-dried plant material was added to 1l of distilled water
and boiled for 10min. The extract thus obtained was ﬁltered
using ﬁlter paper and frozen at −70◦Cu n t i lu s e .T h e
frozen ﬁltrate was freeze dried in a lyophilizer(48–72hours).
The freeze-dried extracts were stored at −70◦Cf o rf u r t h e r
evaluation. These crude extracts were used for the following
experiments.
2.2. Cell Culture. T h eh u m a nm o n o c y t i cc e l ll i n eT H P - 1
(ATCC 202-TIB) [21] was obtained from American Type
Culture Collection (Manassas, VA, USA). These cells express
various receptors that are found in normal monocytes and
have been used as a model system for macrophage biology
and leukemia since 1980. Cells were grown in Dulbecco’s
modiﬁed Eagle’s medium with a high glucose content
(4.5gL−1), supplemented with 10% vol/vol inactivated fetal
calf serum, 1% non-essential amino acids, 1% glutamine,
100UmL−1 penicillin and 10μgm L −1 streptomycin. Cell
lines were maintained in a humidiﬁed atmosphere of 95%
O2–5%CO2 at37◦C.Theculturemediumwaschangedtwice
a week. Cells were seeded in 24-well plates at a density of 2 ×
105 cellsmL−1.Cellswere activated with PMA(100ngmL−1)
and Vitamin D3 (0.1μM). Twenty-four hours after cell
activation, cells were exposed to varying concentrations of
the plant extracts in a fresh serum-free medium in both the
presence and absence of LPS (5μgmL −1).
2.3. MTT Assay. The tetrazolium dye, MTT, is widely
used to assess the viability and/or the metabolic state of
the cells [22]. The MTT-colorimetric monocyte mediated
cytotoxicity assay, based upon the ability of living cells to
reduce3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium
bromide (MTT) into formazan by mitochondrial succinate
dehydrogenase in viable cells. Twenty-four hours after cell
seeding, cells were incubated with varying concentrations
of water extracts of H. triquetrifolium for 24hours at 37◦C.
Following the removal of the plant extracts from each well,
cells were washed in phosphate-buﬀered saline (PBS). The
cells were then incubated in serum-free RPMI to which
MTT (0.5mgmL−1) was added to each well (100μL) and
incubated for a further 4hours. Then the medium was
removed and the cells were incubated for 15min with
100μL of acidic isopropanol (0.08NHCl) to dissolve the
formazan crystals.TheabsorbanceoftheMTT formazan was
determined at 570nm in an enzyme-linked immunosorbent
assay (ELISA) reader. Viability was deﬁned as the ratioEvidence-Based Complementary and Alternative Medicine 3
(expressed as a percentage) of absorbance of treated cells to
untreated cells.
2.4. Lactate Dehydrogenase. In the lactate dehydrogenase
(LDH) assay, the leakage of the cytoplasm-located enzyme
LDH into the extracellular medium is measured. The
presence of the exclusively cytosolic enzyme, LDH, in the
cellculturemediumwasindicativeofcellmembrane damage
[23].
For the LDH assay, 5 × 103 THP-1 were seeded per
well in 96-well microtiter plates. Twenty-four hours after cell
seeding, cells were exposed to varying concentrations of H.
triquetrifolium extracts (0–500μgmL −1). After 24hours of
treatment, the supernatants were collected from each well.
Cell monolayers were then treated with a cell lysis solution
for 30 minutes at room temperature. The cells and the
lysate were collected. LDH activity was measured in both the
supernatants and the cell lysate fractions using CytoTox 96, a
non-radioactive cytotoxicity assay kit (Promega, WI, USA),
in accordance with the manufacturer’s instruction. The
absorbance was determined at 490nm using 96-well plate
ELISAreader. ThepercentofLDHreleasedfromthecellswas
determined using the formula: LDH release = (absorbance
of the supernatant)/(absorbance of the supernatant and cell
lysate) × 100.
2.5. Nitrite Determination. Nitrite determinations were car-
ried out in 50μl aliquots of sample mixed with 200μlo ft h e
Griess reagent [24].
2.6. Quantiﬁcation of TNF-α Production. TNF-α levels were
determined in TNF-α-speciﬁc bioassay using WEHI cell
line, as previously described [25]. WEHI 164 clone 13
ﬁbrosarcoma cells at a concentration of 2 × 104 cells per
100μL were incubated with serially diluted samples in 96-
well ﬂat bottom microtiter plate for 48hours at 37◦C, 5%
CO2.T h e n1 0μLo fa5m gm L −1 MTT tetrazolium solution
in PBS was added to the plate, which was further incubated
for 4hours. The dye was then removed and cells were lysed
by addition of 100μL of isopropanol-5% formic acid. Plates
were read at 620nm on a multiscan bichromatic ELISA
reader (Flow Labs).
2.7. Immunoassay for Cytokines. Commercial ELISA kits
(R&D Systems, Minneapolis, MN, USA) were used to quan-
tify TNF-α and IL-6. The absorbance at 450nm was read
by a microplate reader (model 680; Bio-Rad Laboratories,
Mississauga, ON, Canada), with the wavelength correction
set at 550nm. To calculate the concentration of TNF-α and
IL-6, a standard curve was constructed using serial dilutions
of cytokine standards provided with the kit.
2.8. Reverse Transcriptase-Polymerase Chain Reaction Anal-
ysis. Samples were centrifuged at 1000g for 10min and
total RNA was prepared using Master pure RNA puriﬁcation
kit (EPICENTRE Biotechnologies). Reverse transcriptase-
polymerase chain reaction (RT-PCR) was performed using
the Master pure RNApuriﬁcation kit system (ABgene).Total
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Figure 1: MTT assay in THP-1 cells after overnight treatment
with varying concentrations of extract from H. triquetrifolium.T h e
absorbance of the MTT formazan was determined at 570nm using
ELISA reader. Cell viability was deﬁned as the ratio (expressed
as a percentage) of absorbance of treated cells to untreated cells.
Values represent mean ± SD (∗P < .05 signiﬁcantas compared with
controls)ofthree independent experiments carried outintriplicate.
RNA (0.1μg) was used for a single reaction. Nucleotide
sequences of oligonucleotide primers for the housekeeping
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) plus
the TNF-α or iNOS primer pairs were used for RT-PCR,
which are described elsewhere [26].The reversetranscriptase
reaction was performed at 55◦Cf o r3 0m i n u t e s .T oa m p l i f y
the G3PDH TNF-α and iNOS cDNA, each sample was
denatured at 95◦C for 60s, annealed at 55◦Cf o r6 0 sa n d
extended at 72◦C for 90s. The RT-PCR products were
subjected to agarose gel electrophoresis and stained by
ethidium bromide.
2.9. Statistical Analysis. Error limits cited and error bars
plotted represent simple standard deviations of the mean.
When comparing diﬀerent samples, results were considered
to be statistically diﬀerent when P < .05 (Student’s t-test for
unpaired samples).
3.Results
3.1. Toxicity Measurements. The anti-inﬂammatory eﬀects
of H. triquetrifolium were evaluated here in cells from the
human monocyte cell line. MTT and LDH assays were
carried out in order to evaluate non-toxic concentrations of
H. triquetrifolium.
3.2. MTT Test. The metabolic activity can be evaluated by
measuring the activity of a mitochondrial enzyme succinate
dehydrogenase using the MTT test. This test is widely
used in the in vitro evaluation of the toxicity of plant
extracts. We applied the MTT test to evaluate the safety of
extracts from H. triquetrifolium in cells from the human
monocyte cell line THP-1. Cells were exposed to increasing
concentrations (1–500μgmL −1 of culture medium) of H.
triquetrifolium extracts for 24hours. No sign of any negative
eﬀects was observed after treatment with concentrations
up to 250μgmL −1 (Figure 1). Concentrations higher than
250μgmL −1 caused a signiﬁcant reduction in the cell
viability.4 Evidence-Based Complementary and Alternative Medicine
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Figure 2:LDH leakagefromTHP-1 cells after overnightincubation
with varying concentrations of extracts from H. triquetrifolium.
The leakage of the cytoplasm-located LDH into the extracellular
medium is measured. LDH activity was measured in both the
supernatants andthe cell lysate fractions.Values given represent the
mean±SD(∗P <.05signiﬁcantascomparedwithcontrols)ofthree
independent experiments carried out in triplicate.
3.3. LDH Release Test. Membrane integrity can be evaluated
by measuring LDH activity. LDH, an enzyme located in the
cytoplasm, catalyses the conversion of lactate and pyruvate.
When LDH is found in the media of the cells, there are
two possible causes: the ﬁrst is cellular death and the second
is a “leak” in a cell membrane. When cells are disrupted,
the LDH activity is elevated. Results obtained indicate no
signiﬁcantchangesinLDHlevelsintheculturemediumafter
exposure to extracts of H. triquetrifolium at concentration
up to 125mgmL−1. A slight, but not signiﬁcant, increase
was observed after treatment with concentration of 250 and
500μgmL −1 (Figure 2).
Based on the MTT and LDH results, we decided to
exclude concentrations of 500mgmL−1 and to use concen-
trations below 250μgmL −1 in the following experiments.
3.4. LPS-Induced No Production. Figure 3 shows the dose-
dependent inhibition of the LPS-mediated production of
NO by H. triquetrifolium extracts. Hypericum triquetrifolium
extracts inhibited NO production by cultured THP-1 in
a dose-dependent manner, reaching the control levels of
untreated cells at a concentration of 250μgmL −1 (Figure 3).
3.5. Pro-Inﬂammatory Cytokines IL-6 and TNF-α. Produc-
tion of IL-6 and TNF-α by cultured THP-1 was tested in
the culture supernatants using commercial ELISAkits. It was
found that THP-1 produced detectable amounts of IL-6 and
TNF-α after stimulation with LPS. Maximal TNF-α and IL-
6 concentrations were detectable in the culture supernatants
4 and 6hours after LPS stimulation, respectively. Therefore,
t h e4a n d6 h o u r st i m ep o i n t sw e r eu s e dt oc h a r a c t e r i z e
the eﬀects of H. triquetrifolium extracts on TNF-α and IL-6
production by cultured THP-1, respectively.
Figure 4 shows the TNF-α secretion into the culture
supernatantofuntreatedandLPS-treatedTHP-1.Hypericum
triquetrifolium extracts inhibited TNF-α production in a
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Figure 3: Dose-dependent inhibition of LPS-mediated production
of NO by H. triquetrifolium extracts. For each concentration
treatment, the level of NO release is represented as a percentage
of the control set at 100%. Values represent mean ± SD (∗P <
.05 signiﬁcant as compared with LPS alone) of three independent
experiments carried out in triplicate.
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Figure 4: Dose-dependent inhibition of LPS-mediated production
of TNF-α by H. triquetrifolium extracts. For each concentration
treatment, the level of TNF-α release is represented as a percentage
of the control set at 100%. The bar heights represent the values of
mean ± SD (∗P < .05 signiﬁcant as compared with LPS alone) of
three independent ELISA experiments carried out in triplicate.
dose-dependent manner, reaching the control levels of
untreated cells at a concentration of 250μgmL −1 (Figure 4).
No eﬀects on the production levels of IL-6 were seen after
LPS treatment in the presence of H. triquetrifolium (data not
shown).
3.6. TNF-α Gene Expression. We further studied the eﬀect of
H. triquetrifolium on TNF-α mRNA in LPS-activated THP-
1 cells in the presence and absence of varying concentrations
ofH.triquetrifolium.I nthissyst em,r ev erse-transcribedRN A
products were ampliﬁed simultaneously with both internal
control gene primers (G3PDH) and TNF-α primers in the
same tube. Data presented in Figure 5 demonstrate that
both ampliﬁed human G3PDH gene (983bp) and TNF-α
gene (325bp) products ampliﬁed at the expected regions.
Cells cultured with H. triquetrifolium did not produce anyEvidence-Based Complementary and Alternative Medicine 5
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Figure 5: Hypericum triquetrifolium extract suppresses LPS-
induced TNF-α gene expression in human THP-1 cells. RNAs
from LPS-treated, extract-treated or LPS plus extract-treated THP-
1 cells were reverse transcribed and ampliﬁed with human G3PDH
and TNF-α primer pairs and electrophoresed. G3PDH and TNF-α
messages ampliﬁed at around 983 and 325bp, respectively. Extract
demonstrated a signiﬁcant suppression of endogenous TNF-α
message (lane D) compared with that in the LPS-treated culture
(lane B). These results are from a single experiment, which was
repeated three times.
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Figure 6: Hypericum triquetrifolium extract suppresses LPS-
induced iNOS gene expression in human THP-1 cells. RNAs from
LPS-treated, extract-treated or LPS plus extract-treated THP-1
cells were reverse transcribed and ampliﬁed with human G3PDH
and iNOS primer pairs and electrophoresed. Extract demonstrated
complete suppression of endogenous iNOS message (lane D)
compared with that in the LPS-treated culture (lane B). These
results are from a single experiment, which was repeated three
times, using THP-1 cells.
signiﬁcant eﬀect on TNF-α mRNA. However, the extract
signiﬁcantly suppressed the LPS-induced TNF-α message
compared with expression in the LPS-treated culture.
3.7. INOS Gene Expression. Figure 6 shows that treatment of
THP-1 cells with extracts of H. triquetrifolium completely
suppressed the LPS-induced iNOS gene expression. Data
presented in Figure 6 demonstrate that both ampliﬁed
human G3PDH gene (983bp) and iNOS gene (300bp)
products ampliﬁed at the expected regions. Cells cultured
with H. triquetrifolium did not produce any signiﬁcant eﬀect
oniNOSmRNA.The extract,however, totallysuppressed the
LPS-inducediNOSmessage comparedwith expression in the
LPS-treated culture (Figure 6).
4.Discussion
Inﬂammation is the ﬁrst response of the immune system
to infection or irritation. It is caused by cytokines such as
TNF-α, IL-1 and IL-6 and by eicosanoid such as PGE2.T h u s ,
inhibitorsofthesecytokineshavebeenconsideredasacandi-
date for anti-inﬂammatory drugs. Monocytes/macrophages
arekeymediators ofinﬂammation andarewidelydistributed
in the body [27, 28]. Therefore, the monocytic cell line
THP-1, which represents an appropriate model system to
study immune responses, was utilized to investigate the anti-
inﬂammatory eﬀects of H. triquetrifolium.
Herbal medicines containing H. triquetrifolium have
been used in traditional Arab herbal medicine to treat var-
ious inﬂammatory diseases. However, only few studies have
been conducted to evaluate the eﬀects of H. triquetrifolium
on inﬂammation. In this study, we show that H. triquetri-
folium could modulate the regulatory mechanism of NO and
pro-inﬂammatory cytokines (TNF-α and IL-6) in the LPS-
activated THP-1 cells. Hypericum triquetrifolium inhibited
the production of NO and TNF-α and the expression of
iNOS and TNF-α but not of IL-6.
4.1. The Eﬀect on NOS. NO is a free radical produced
from l-arginine by nitric oxide synthases (NOSs). It is
also an important cellular second messenger. NO is one
of the cellular mediators of physiological and pathological
processes [21, 29]. At adequate concentrations, NO can
generate or modify intracellular signals, thereby aﬀecting
the function of immune cells, tumor cells and resident cells
of diﬀerent tissues and organs. However, its uncontrolled
release can cause inﬂammatory destruction of target tissue
during an infection. Three diﬀerent isoforms of NOS have
been discovered: endothelial NOS, neuronal NOS and iNOS.
The former two are constitutively expressed in the body,
whereas the latterisan inducibleenzyme highly expressed by
inﬂammatory stimuli in certain cells such as macrophages. A
signiﬁcantly increased amount of NO synthesized by iNOS
participates in provoking inﬂammatory process and acts
synergistically with other inﬂammatory mediators. Inhibi-
tion of iNOS activity or downregulation of iNOS expression
may be beneﬁcial to reduce the inﬂammatory response.
Therefore, it is meaningful to evaluate the eﬀects of extracts
from H. triquetrifolium on NOS (eﬀect on NO production)
since NO is one of the inﬂammatory mediators. Our results
demonstrate for the ﬁrst time that H. triquetrifolium extracts
downregulate the production of NO by downregulating the
transcription of the iNOSgene. The transcription was totally
inhibited by non-toxic concentration of H. triquetrifolium
extract (250μgH. triquetrifolium/mL). Similar results were
foundwithmedicinalplant-derivedfactors(e.g.,ﬂavonoids).
Using LPS/cytokine-treated macrophages or macrophage-
like cell lines, varieties of ﬂavonoids including apigenin,
luteolin and quercetin were found to inhibit NO produc-
tion. However, studies on the mechanism have shown that
ﬂavonoids did not signiﬁcantly inhibit iNOS. They were
shown to downregulate iNOS induction, thereby reducing
NO production [30]. Recently, Moutan Cortex, a traditional
medicine used to remove heat from the blood, promote
blood circulation and alleviate blood stasis, has been found
to exhibit anti-inﬂammatory eﬀects through the inhibition
of iNOS and COX-2 expression by suppressing the phospho-
rylation of I-κBα and the activation of NF-κB[ 31].6 Evidence-Based Complementary and Alternative Medicine
4.2. The Eﬀect on the Production of Pro-Inﬂammatory
Cytokines. In addition to iNOS, several cytokines are inti-
mately associated with inﬂammatory diseases. In particular,
TNF-α and IL-1 are prominent contributors to chronic
inﬂammatory disorders including rheumatoid arthritis (RA)
[32]. TNF-α and IL-1 receptor antagonists have been clini-
cally successful in improving the symptoms in RA patients.
SAIDs, such as prednisolone and dexamethasone, are known
to reduce the production of these cytokines. In recent years,
various medicinal plant-derived factors have been reported
to regulate the production of pro-inﬂammatory cytokines.
Flavonids, such as amoradicin, genistein and silybin, were
proved to inhibit TNF-α production from LPS-treated
RAW 264.7 cells [33]. Baicalin inhibited the induction
of IL-1, IL-6, TNF-α, interferon-γ, monocyte chemotactic
protein-1, macrophage inﬂammatory protein (MIP)-1 and
MIP-1 at protein as well as at RNA levels from human
blood monocytes treated with staphylococcal enterotoxin
[34]. In this study, we have shown that H. triquetrifolium
inhibits the production of LPS-induced TNF-α production
bydownregulatingthetranscriptionoftheTNFgene.Similar
results were found using diﬀerent medicinal plants. For
example, feverfew extracts were found to eﬀectively reduce
LPS-mediated TNF-α and CCL2 (MCP-1) releases by THP-1
cells [28]. Moutan Cortex extracts were reported to exhibit
anti-inﬂammatory eﬀects through the inhibition of iNOS
and COX-2 expression by suppressing the phosphorylation
of I-κBα and the activation of NF-κB. Uncaria tomentosa
extracts inhibited the MAP kinase-signaling pathway and
altered cytokine expression in THP-1 monocyte-like cells
with U. tomentosa [31]. Hypericum triquetrifolium inhibits
the production of LPS-induced TNF-α productionby down-
regulating the transcription of the TNF gene but has no
signiﬁcant eﬀects on the production levels of IL-6. These
results suggest that the anti-inﬂammatory eﬀects of H.
triquetrifolium are mediated via the downregulation of the
transcription of the TNF gene.
5.Conclusions
Results obtained in this in vitro study indicate that extracts
from H. triquetrifolium inhibit the production of LPS-
induced TNF-α and NO production by downregulating the
transcription of TNF-α and NO genes, respectively.
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